Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles

Om Prakash Ganda, M.D., M.B.,B.S.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Ganda OP, Plutzky J, Sanganalmath SK, Bujas-Bobanovic M, Koren A, Mandel J, Letierce A, Leiter LA. Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials. Diabetes Obes Metab. 2018 10; 20(10):2389-2398. PMID: 29802688.
    View in: PubMed
  2. Ganda OP, Bhatt DL, Mason RP, Miller M, Boden WE. Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management. J Am Coll Cardiol. 2018 Jul 17; 72(3):330-343. PMID: 29935936.
    View in: PubMed
  3. Hafida S, Ganda OP, Gabbay RA. CHAPTER 1. Clinical guideline for adults with diabetes. Am J Manag Care. 2018 Jun; 24(7 Spec No.):SP209-SP225. PMID: 29938994.
    View in: PubMed
  4. Munshi M, Blair E, Ganda OP, Gabbay RA. CHAPTER 4. Guideline for the care of the older adult with diabetes. Am J Manag Care. 2018 Jun; 24(7 Spec No.):SP240-SP252. PMID: 29938997.
    View in: PubMed
  5. Ganda OP, Gabbay RA. Joslin Diabetes Center Clinical Oversight Committee. Am J Manag Care. 2018 Jun; 24(7 Spec No.):SP206-SP207. PMID: 29938993.
    View in: PubMed
  6. Hamdy O, Ganda OP, Maryniuk M, Gabbay RA. CHAPTER 2. Clinical nutrition guideline for overweight and obese adults with type 2 diabetes (T2D) or prediabetes, or those at high risk for developing T2D. Am J Manag Care. 2018 Jun; 24(7 Spec No.):SP226-SP231. PMID: 29938995.
    View in: PubMed
  7. Ganda OP, Segal A, Blair E, Beaser R, Gaglia J, Halprin E, Gabbay RA. CHAPTER 5. Clinical guideline for pharmacological management of adults with type 2 diabetes. Am J Manag Care. 2018 Jun; 24(7 Spec No.):SP253-SP262. PMID: 29938998.
    View in: PubMed
  8. Ganda OP, Gabbay RA. From the editors: bringing the Joslin Clinical Guidelines to the diabetes care community. Am J Manag Care. 2018 Jun; 24(7 Spec No.):SP205. PMID: 29938992.
    View in: PubMed
  9. Brown FM, Anderson-Haynes SE, Blair E, Serdy S, Halprin E, Feldman A, O'Brien KE, Ghiloni S, Suhl E, Rizzotto JA, Ganda OP, Gabbay RA. CHAPTER 3. Guideline for detection and management of diabetes in pregnancy. Am J Manag Care. 2018 Jun; 24(7 Spec No.):SP232-SP239. PMID: 29938996.
    View in: PubMed
  10. Ganda OP, Mitri J. Current Consensus and Controversies in Guidelines for Lipid and Hypertension Management in Diabetes. Curr Cardiol Rep. 2016 11; 18(11):114. PMID: 27747489.
    View in: PubMed
  11. Pfammatter A, Spring B, Saligram N, Davé R, Gowda A, Blais L, Arora M, Ranjani H, Ganda O, Hedeker D, Reddy S, Ramalingam S. mHealth Intervention to Improve Diabetes Risk Behaviors in India: A Prospective, Parallel Group Cohort Study. J Med Internet Res. 2016 08 05; 18(8):e207. PMID: 27496271.
    View in: PubMed
  12. Ganda OP. Statin-induced diabetes: incidence, mechanisms, and implications. F1000Res. 2016; 5. PMID: 27408693; PMCID: PMC4926726.
  13. Ganda OP. Antihyperglycemic drugs and cardiovascular outcomes in type 2 diabetes. Cleve Clin J Med. 2016 May; 83(5 Suppl 1):S11-7. PMID: 27176677.
    View in: PubMed
  14. Ganda OP. Comment on Jakubowicz et al. Fasting Until Noon Triggers Increased Postprandial Hyperglycemia and Impaired Insulin Response After Lunch and Dinner in Individuals With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2015;38:1820-1826. Diabetes Care. 2016 Feb; 39(2):e28. PMID: 26798157.
    View in: PubMed
  15. Ganda OP. Failure to Report Financial Disclosure Information. JAMA. 2015 Oct 06; 314(13):1404. PMID: 26441194.
    View in: PubMed
  16. Ganda OP. Clinician Understanding of Cholesterol Treatment Guidelines--Reply. JAMA. 2015 Jun 16; 313(23):2382. PMID: 26080351.
    View in: PubMed
  17. Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovic L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY - CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN - 2015. Endocr Pract. 2015 Apr; 21 Suppl 1:1-87. PMID: 26131596.
    View in: PubMed
  18. Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovic L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F. American association of clinical endocrinologists and american college of endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015. Endocr Pract. 2015 Apr; 21 Suppl 1:1-87. PMID: 25869408.
    View in: PubMed
  19. Handelsman Y, Bloomgarden ZT, Grunberger G, Umpierrez G, Zimmerman RS, Bailey TS, Blonde L, Bray GA, Cohen AJ, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda OP, Garber AJ, Garvey WT, Henry RR, Hirsch IB, Horton ES, Hurley DL, Jellinger PS, Jovanovic L, Lebovitz HE, LeRoith D, Levy P, McGill JB, Mechanick JI, Mestman JH, Moghissi ES, Orzeck EA, Pessah-Pollack R, Rosenblit PD, Vinik AI, Wyne K, Zangeneh F. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY--CLINICAL PRACTICE GUIDELINES FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN--2015--EXECUTIVE SUMMARY. Endocr Pract. 2015 Apr; 21(4):413-37. PMID: 27408942.
    View in: PubMed
  20. Ganda OP. Deciphering cholesterol treatment guidelines: a clinician's perspective. JAMA. 2015 Mar 10; 313(10):1009-10. PMID: 25756432; PMCID: PMC4429891.
  21. Beverly EA, Fitzgerald SM, Brooks KM, Hultgren BA, Ganda OP, Munshi M, Weinger K. Impact of reinforcement of diabetes self-care on poorly controlled diabetes: a randomized controlled trial. Diabetes Educ. 2013 Jul-Aug; 39(4):504-14. PMID: 23640303.
    View in: PubMed
  22. Beverly EA, Fitzgerald S, Sitnikov L, Ganda OP, Caballero AE, Weinger K. Do older adults aged 60-75 years benefit from diabetes behavioral interventions? Diabetes Care. 2013 Jun; 36(6):1501-6. PMID: 23315603; PMCID: PMC3661804.
  23. Beverly EA, Ganda OP, Ritholz MD, Lee Y, Brooks KM, Lewis-Schroeder NF, Hirose M, Weinger K. Look who's (not) talking: diabetic patients' willingness to discuss self-care with physicians. Diabetes Care. 2012 Jul; 35(7):1466-72. PMID: 22619085; PMCID: PMC3379588.
  24. Ganda OP, Jumes CG, Abrahamson MJ, Molla M. Quantification of concordance and discordance between apolipoprotein-B and the currently recommended non-HDL-cholesterol goals for cardiovascular risk assessment in patients with diabetes and hypertriglyceridemia. Diabetes Res Clin Pract. 2012 Jul; 97(1):51-6. PMID: 22459987; PMCID: PMC3758365.
  25. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocr Pract. 2012 Mar-Apr; 18 Suppl 1:1-78. PMID: 22522068.
    View in: PubMed
  26. Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA. American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary. Endocr Pract. 2012 Mar-Apr; 18(2):269-93. PMID: 22507559.
    View in: PubMed
  27. Jellinger P, Smith D, Mehta A, Ganda O, Handelsman Y, Rodbard H, Shepherd M, Seibel J. American association of clinical endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis. Endocr Pract. 2012 Mar; 18(Suppl 1):1-78. PMID: 25946309.
    View in: PubMed
  28. Weinger K, Beverly EA, Lee Y, Sitnokov L, Ganda OP, Caballero AE. The effect of a structured behavioral intervention on poorly controlled diabetes: a randomized controlled trial. Arch Intern Med. 2011 Dec 12; 171(22):1990-9. PMID: 21986346; PMCID: PMC3487475.
  29. Roshan B, Ganda OP, Desilva R, Ganim RB, Ward E, Haessler SD, Polisecki EY, Asztalos BF, Schaefer EJ. Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature. J Clin Lipidol. 2011 Nov-Dec; 5(6):493-9. PMID: 22108153; PMCID: PMC4565181.
  30. Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda O, Garber AJ, Hirsch IB, Horton ES, Ismail-Beigi F, Jellinger PS, Jones KL, Jovanovic L, Lebovitz H, Levy P, Moghissi ES, Orzeck EA, Vinik AI, Wyne KL. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011 Mar-Apr; 17 Suppl 2:1-53. PMID: 21474420.
    View in: PubMed
  31. Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, Dagogo-Jack S, Davidson JA, Einhorn D, Ganda O, Garber AJ, Hirsch IB, Horton ES, Ismail-Beigi F, Jellinger PS, Jones KL, Jovanovic L, Lebovitz H, Levy P, Moghissi ES, Orzeck EA, Vinik AI, Wyne KL. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. Endocr Pract. 2011 Mar-Apr; 17(2):287-302. PMID: 21474421.
    View in: PubMed
  32. Ganda OP, Fonseca VA. Salt sensitivity, insulin resistance, and public health in India. Endocr Pract. 2010 Nov-Dec; 16(6):940-4. PMID: 20439237.
    View in: PubMed
  33. Ganda OP. The role of bile acid sequestrants in the management of type 2 diabetes mellitus. Metab Syndr Relat Disord. 2010 Dec; 8 Suppl 1:S15-21. PMID: 21034179; PMCID: PMC3135893.
  34. Ganda OP. Refining lipoprotein assessment in diabetes: apolipoprotein B makes sense. Endocr Pract. 2009 May-Jun; 15(4):370-6. PMID: 19454383.
    View in: PubMed
  35. Misra R, Patel T, Kotha P, Raji A, Ganda O, Banerji M, Shah V, Vijay K, Mudaliar S, Iyer D, Balasubramanyam A. Prevalence of diabetes, metabolic syndrome, and cardiovascular risk factors in US Asian Indians: results from a national study. J Diabetes Complications. 2010 May-Jun; 24(3):145-53. PMID: 19303333.
    View in: PubMed
  36. Ganda OP. A targeted, multifactorial intervention reduced mortality in patients with type 2 diabetes and microalbuminuria. ACP J Club. 2008 Aug 19; 149(2):4. PMID: 18710177.
    View in: PubMed
  37. Ganda OP. Review: meglitinide analogues reduce glucose levels in type 2 diabetes, but morbidity and mortality effects are unknown. ACP J Club. 2007 Nov-Dec; 147(3):65. PMID: 17975867.
    View in: PubMed
  38. Misra A, Ganda OP. Migration and its impact on adiposity and type 2 diabetes. Nutrition. 2007 Sep; 23(9):696-708. PMID: 17679049.
    View in: PubMed
  39. Ganda OP. Ask the doctor. I have been taking niacin for several years, and it has helped keep my good and bad cholesterol in their healthy ranges. Now I have been diagnosed with diabetes, and my doctor forbids me from taking niacin any more. What's the reasoning behind this? Harv Heart Lett. 2006 Aug; 16(12):8. PMID: 16918036.
    View in: PubMed
  40. Smaldone A, Ganda OP, McMurrich S, Hannagan K, Lin S, Caballero AE, Weinger K. Should group education classes be separated by type of diabetes? Diabetes Care. 2006 Jul; 29(7):1656-8. PMID: 16801595; PMCID: PMC1584305.
  41. Shrikhande G, Khaodhiar L, Scali S, Lima C, Hubbard M, Dudley K, Ganda O, Ferran C, Veves A. Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. J Vasc Surg. 2006 Apr; 43(4):760-70; discussion 770-1. PMID: 16616233.
    View in: PubMed
  42. Ganda OP. The role of lipid management in diabetes. Cardiol Clin. 2005 May; 23(2):153-64, vi. PMID: 15694744.
    View in: PubMed
  43. Ganda OP. Insulin resistance syndrome: implications for the Asian American population. Endocr Pract. 2003 Sep-Oct; 9 Suppl 2:31-4. PMID: 14698972.
    View in: PubMed
  44. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, Hellman R, Jellinger PS, Kendall D, Krauss RM, Neufeld ND, Petak SM, Rodbard HW, Seibel JA, Smith DA, Wilson PW. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003 May-Jun; 9(3):237-52. PMID: 12924350.
    View in: PubMed
  45. Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. Arch Intern Med. 2002 Jul 22; 162(14):1568-76. PMID: 12123399.
    View in: PubMed
  46. Ganda OP. Review: interventions that lower cholesterol levels or blood pressure in diabetic patients prevent cardiovascular disease. ACP J Club. 2002 Jul-Aug; 137(1):3. PMID: 12093202.
    View in: PubMed
  47. Ganda OP. Lipoatrophy, lipodystrophy, and insulin resistance. Ann Intern Med. 2000 Aug 15; 133(4):304-6. PMID: 10929174.
    View in: PubMed
  48. Jellinger PS, Dickey RA, Ganda OP, Mehta AE, Nguyen TT, Rodbard HW, Seibel JA, Shepherd MD, Smith DA. AACE medical guidelines for clinical practice for the diagnosis and treatment of dyslipidemia and prevention of atherogenesis. Endocr Pract. 2000 Mar-Apr; 6(2):162-213. PMID: 11428356.
    View in: PubMed
  49. Ganda OP. Management of patients with diabetes and "abnormal" blood pressure: selection of antihypertensive agents. Endocr Pract. 1996 Jul-Aug; 2(4):276-9. PMID: 15251530.
    View in: PubMed
  50. Raskin P, Ganda OP, Schwartz S, Willard D, Rosenstock J, Lodewick PA, Cressman MD, Phillipson B, Weiner B, McGovern ME, et al. Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia. Am J Med. 1995 Oct; 99(4):362-9. PMID: 7573090.
    View in: PubMed
  51. Ganda OP, Arkin CF. Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes. Diabetes Care. 1992 Oct; 15(10):1245-50. PMID: 1425083.
    View in: PubMed
  52. Warram JH, Laffel LM, Ganda OP, Christlieb AR. Coronary artery disease is the major determinant of excess mortality in patients with insulin-dependent diabetes mellitus and persistent proteinuria. J Am Soc Nephrol. 1992 Oct; 3(4 Suppl):S104-10. PMID: 1457752.
    View in: PubMed
  53. Ganda OP. Microalbuminuria: measurements, determinants and accompaniments. Diabetes Res Clin Pract. 1991 Mar; 11(3):137-9. PMID: 2036935.
    View in: PubMed
  54. Brown FM, Vinik AI, Ganda OP, Adri MN, Rabinowe SL. Different effects of duration on prevalence of anti-adrenal medullary and pancreatic islet cell antibodies in type I diabetes mellitus. Horm Metab Res. 1989 Aug; 21(8):434-7. PMID: 2676819.
    View in: PubMed
  55. Ganda OP. Markedly increased erythrocyte sedimentation rate, hyperfibrinogenemia, and peripheral vascular disease in diabetic patients: association with clinical implications. Am J Med. 1988 Oct; 85(4):584-5. PMID: 3177418.
    View in: PubMed
  56. Lokich JJ, Ganda OP, O'Hara CJ, Warren KW, Moertel CG, Klee G. Alpha-fetoprotein associated with islet cell tumors. Am J Clin Oncol. 1987 Apr; 10(2):133-5. PMID: 2436469.
    View in: PubMed
  57. Ganda OP, Srikanta S, Gleason RE, Soeldner JS, Eisenbarth GS. Diminished A-cell secretion in the early phase of type I diabetes mellitus. Metabolism. 1986 Nov; 35(11):1074-7. PMID: 3534518.
    View in: PubMed
  58. Kaye WA, Adri MN, Soeldner JS, Rabinowe SL, Kaldany A, Kahn CR, Bistrian B, Srikanta S, Ganda OP, Eisenbarth GS. Acquired defect in interleukin-2 production in patients with type I diabetes mellitus. N Engl J Med. 1986 Oct 09; 315(15):920-4. PMID: 3531850.
    View in: PubMed
  59. Battinelli T, Gleason RE, Ganda OP, Cunningham LN. Height-weight indices and blood lipid levels in normal controls and offspring of conjugal diabetics. Hum Biol. 1986 Aug; 58(4):601-14. PMID: 3759058.
    View in: PubMed
  60. Soeldner JS, Tuttleman M, Srikanta S, Ganda OP, Eisenbarth GS. Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure. N Engl J Med. 1985 Oct 03; 313(14):893-4. PMID: 3897867.
    View in: PubMed
  61. Eisenbarth GS, Srikanta S, Fleischnick E, Ganda OP, Jackson RA, Brink SJ, Soeldner JS, Yunis EJ, Alper C. Progressive autoimmune beta cell insufficiency: occurrence in the absence of high-risk HLA alleles DR3, DR4. Diabetes Care. 1985 Sep-Oct; 8(5):477-80. PMID: 3876922.
    View in: PubMed
  62. Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS. First-degree relatives of patients with type I diabetes mellitus. Islet-cell antibodies and abnormal insulin secretion. N Engl J Med. 1985 Aug 22; 313(8):461-4. PMID: 3894969.
    View in: PubMed
  63. Ganda OP, Soeldner JS, Gleason RE. Alterations in plasma lipids in the presence of mild glucose intolerance in the offspring of two type II diabetic parents. Diabetes Care. 1985 May-Jun; 8(3):254-60. PMID: 3891266.
    View in: PubMed
  64. Srikanta S, Ganda OP, Gleason RE, Jackson RA, Soeldner JS, Eisenbarth GS. Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose. Diabetes. 1984 Aug; 33(8):717-20. PMID: 6378696.
    View in: PubMed
  65. Srikanta S, Ganda OP, Jackson RA, Brink SJ, Fleischnick E, Yunis E, Alper C, Soeldner JS, Eisenbarth GS. Pre-type 1 (insulin-dependent) diabetes: common endocrinological course despite immunological and immunogenetic heterogeneity. Diabetologia. 1984 Jul; 27 Suppl:146-8. PMID: 6383919.
    View in: PubMed
  66. Ganda OP, Srikanta S, Brink SJ, Morris MA, Gleason RE, Soeldner JS, Eisenbarth GS. Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus. Diabetes. 1984 Jun; 33(6):516-21. PMID: 6373458.
    View in: PubMed
  67. Ganda OP. Pentamidine and hypoglycemia. Ann Intern Med. 1984 Mar; 100(3):464. PMID: 6364914.
    View in: PubMed
  68. Patel YC, Ganda OP, Benoit R. Pancreatic somatostatinoma: abundance of somatostatin-28(1-12)-like immunoreactivity in tumor and plasma. J Clin Endocrinol Metab. 1983 Nov; 57(5):1048-53. PMID: 6137494.
    View in: PubMed
  69. Ganda OP. Morbidity and mortality from diabetes mellitus: a look at preventable aspects. Am J Public Health. 1983 Oct; 73(10):1156-8. PMID: 6614269; PMCID: PMC1651096.
  70. Srikanta S, Ganda OP, Jackson RA, Gleason RE, Kaldany A, Garovoy MR, Milford EL, Carpenter CB, Soeldner JS, Eisenbarth GS. Type I diabetes mellitus in monozygotic twins: chronic progressive beta cell dysfunction. Ann Intern Med. 1983 Sep; 99(3):320-6. PMID: 6351687.
    View in: PubMed
  71. Vlachokosta FV, Asmal AC, Ganda OP, Aoki TT. The effect of strict control with the artificial beta-cell on plasma lipid levels in insulin-dependent diabetes. Diabetes Care. 1983 Jul-Aug; 6(4):351-5. PMID: 6617412.
    View in: PubMed
  72. Ganda OP, Williamson JR, Soeldner JS, Gleason RE, Kilo C, Kaldany A, Miller JP, Garovoy MR, Carpenter CB. Muscle capillary basement membrane width and its relationship to diabetes mellitus in monozygotic twins. Diabetes. 1983 Jun; 32(6):549-56. PMID: 6685073.
    View in: PubMed
  73. Srikanta S, Ganda OP, Eisenbarth GS, Soeldner JS. Islet-cell antibodies and beta-cell function in monozygotic triplets and twins initially discordant for Type I diabetes mellitus. N Engl J Med. 1983 Feb 10; 308(6):322-5. PMID: 6337325.
    View in: PubMed
  74. Blanc MH, Ganda OP, Gleason RE, Soeldner JS. Improvement of lipid status in diabetic boys: the 1971 and 1979 Joslin Camp lipid levels. Diabetes Care. 1983 Jan-Feb; 6(1):64-6. PMID: 6839923.
    View in: PubMed
  75. Ganda OP. The role of gastrointestinal and neuronal peptides in the pathophysiology of diabetes mellitus. Diabetes Care. 1981 May-Jun; 4(3):435-42. PMID: 6124374.
    View in: PubMed
  76. Rhie FH, Ganda OP, Bern MM, Soeldner JS, Gerson B, Azizi F. Insulin resistance and monoclonal gammopathy. Metabolism. 1981 Jan; 30(1):41-5. PMID: 6780752.
    View in: PubMed
  77. Christlieb AR, Warram JH, Królewski AS, Busick EJ, Ganda OP, Asmal AC, Soeldner JS, Bradley RF. Hypertension: the major risk factor in juvenile-onset insulin-dependent diabetics. Diabetes. 1981; 30(Suppl 2):90-6. PMID: 7297776.
    View in: PubMed
  78. Ganda OP. Pathogenesis of macrovascular disease in the human diabetic. Diabetes. 1980 Nov; 29(11):931-42. PMID: 7000590.
    View in: PubMed
  79. Ganda OP, Soeldner JS. Capillary basement membrane thickness in monozygotic twins. Lancet. 1980 Sep 20; 2(8195 pt 1):650. PMID: 6107443.
    View in: PubMed
  80. Ganda OP, Soeldner JS, Gleason RE, Cleator IG, Reynolds C. Metabolic effects of glucose, mannose, galactose, and fructose in man. J Clin Endocrinol Metab. 1979 Oct; 49(4):616-22. PMID: 479351.
    View in: PubMed
  81. Ruderman NB, Ganda OP, Johansen K. The effect of physical training on glucose tolerance and plasma lipids in maturity-onset diabetes. Diabetes. 1979 Jan; 28 Suppl 1:89-92. PMID: 761721.
    View in: PubMed
  82. Day JL, Johansen K, Ganda OP, Soeldner JS, Gleason RE, Midgley W. Factors governing insulin and glucagon responses during normal meals. Clin Endocrinol (Oxf). 1978 Nov; 9(5):443-54. PMID: 719912.
    View in: PubMed
  83. Sawin CT, Hershman JM, Fernandez-Garcia R, Ghazvinian S, Ganda OP, Azukizawa M. A comparison of thyroxine and desicatted thyroid in patients with primary hypothyroidism. Metabolism. 1978 Oct; 27(10):1518-25. PMID: 99633.
    View in: PubMed
  84. Ganda OP, Day JL, Soeldner JS, Connon JJ, Gleason RE. Reproducibility and comparative analysis of repeated intravenous and oral glucose tolerance tests. Diabetes. 1978 Jul; 27(7):715-25. PMID: 658617.
    View in: PubMed
  85. Ganda OP, Sawin CT, Iber F, Glennon JA, Mitchell ML. Transient suppression of growth hormone secretion after chronic ethanol intake. Alcohol Clin Exp Res. 1978 Jul; 2(3):297-9. PMID: 356654.
    View in: PubMed
  86. Ganda OP, Soeldner JS. "Somatostatinoma": follow-up studies. N Engl J Med. 1977 Dec 15; 297(24):1352-3. PMID: 199841.
    View in: PubMed
  87. Weglicki WB, Ganda OP, Soeldner JS, Murawski BJ, Cohn LH, Couch NP. Portacaval diversion for severe hypercholesterolemia. Report of a case with measurements of glucose tolerance, insulin, and glucagon levels. Arch Surg. 1977 May; 112(5):634-6. PMID: 857765.
    View in: PubMed
  88. Ganda OP, Soeldner JS, Gleason RE, Smith TM, Kilo C, Williamson JR. Monozygotic triplets with discordance for diabetes mellitus and diabetic microangiopathy. Diabetes. 1977 May; 26(5):469-79. PMID: 192616.
    View in: PubMed
  89. Ganda OP, Weir GC, Soeldner JS, Legg MA, Chick WL, Patel YC, Ebeid AM, Gabbay KH, Reichlin S. "Somatostatinoma": a somatostatin-containing tumor of the endocrine pancreas. N Engl J Med. 1977 Apr 28; 296(17):963-7. PMID: 321960.
    View in: PubMed
  90. Ganda OP, Soeldner SS. Genetic, acquired, and related factors in the etiology of diabetes mellitus. Arch Intern Med. 1977 Apr; 137(4):461-9. PMID: 322629.
    View in: PubMed
  91. Ganda OP, Rossini AA, Like AA. Studies on streptozotocin diabetes. Diabetes. 1976 Jul; 25(7):595-603. PMID: 132382.
    View in: PubMed
  92. Ganda OP, Aoki TT, Soeldner JS, Morrison RS, Cahill GF. Hormone-fuel concentrations in anephric subjects. Effect of hemodialysis (with special reference to amino acids). J Clin Invest. 1976 Jun; 57(6):1403-11. PMID: 932188; PMCID: PMC436798.
  93. Ganda OP, Ruderman NB. Muscle nitrogen metabolism in chronic hepatic insufficiency. Metabolism. 1976 Apr; 25(4):427-35. PMID: 1263837.
    View in: PubMed
  94. Rossini AA, Aoki TT, Ganda OP, Soeldner JS, Cahill GF. Alanine-induced amino acid interrelationships. Metabolism. 1975 Oct; 24(10):1185-92. PMID: 1165733.
    View in: PubMed
  95. Ganda OP, Kahn CB, Soeldner JS, Gleason RE. Dynamics of tolbutamide, glucose, and insulin interrelationships following varying doses of intravenous tolbutamide in normal subjects. Diabetes. 1975 Apr; 24(4):354-67. PMID: 1132601.
    View in: PubMed
  96. Ganda OP, Caplan HI. Rheumatoid disease without joint involvement. JAMA. 1974 Apr 15; 228(3):338-9. PMID: 4544651.
    View in: PubMed
  97. Ganda OP, Mangalik A. Delayed toxic effect of busulfan on the marrow. J Assoc Physicians India. 1973 Jun; 21(6):511-6. PMID: 4525264.
    View in: PubMed
  98. Ganda OP, Bhatia ML, Ahuja MM. Studies on peripheral metabolism of glucose and free fatty acids (forearm preparation) in various clinical types of Indian diabetics. Indian J Med Res. 1971 Oct; 59(10):1641-52. PMID: 5159001.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Ganda's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (317)
Explore
_
Co-Authors (27)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_